Global Primary Cells Market to Witness Growth at 11.41% CAGR to Accrue USD 2.88 Bn by 2030, with North America Dominating the Industry Due to Technological Advancements, States Kings Research


The global primary cells market is estimated to grow at a strong CAGR of 11.41% from 2023 to 2030. Some of the major factors fueling the market growth include its growing popularity in in-vitro testing and drug screening, advancements in cancer therapies, and rising adoption of cutting-edge technologies.

Dubai, UAE, Oct. 26, 2023 (GLOBE NEWSWIRE) — As per the latest report released by Kings Research, the global Primary Cells Market size was recorded at USD 1.23 billion in 2022 and is expected to grow to USD 2.88 billion by 2030, exhibiting a CAGR of 11.41% through the forecast period of 2023-2030. Due to the importance of primary cell cultures in in-vivo settings, they are gaining popularity for in vitro testing and drug screening. Primary cell cultures are increasingly being used for in vitro testing and drug screening due to their precision, specificity, reproducibility, and technological advancements in their maintenance and production.

Using primary cells for toxicity and efficacy screening of potential drug candidates can decrease the reliance on animal testing while enhancing the precision of the initial drug screening process. With their high-quality contextual models of normal cell physiology and signaling, disease, and therapeutic drugs, these cells are starting to become a crucial tool in cell and molecular biology research. They are important for understanding the biology of cancer and screening potential anticancer drugs. For examining medication response and toxicity, primary cell cultures are more pertinent since they maintain the genetic and phenotypic characteristics of the cells in vivo.


Get a Sample PDF of the Report:

Trending Now: Advanced Gene Editing Methodology Empowers the Next Wave of Cell and Gene Therapies

A novel strategy for genetically engineering cells promises considerable advancements over existing techniques in terms of speed, effectiveness, and cellular toxicity reduction. Researchers from the Perelman School of Medicine at the University of Pennsylvania conducted a study that suggests the strategy may also be used to produce cutting-edge cell treatments for cancer and other diseases.

Global Primary Cells Market Overview:

Report Attributes Details  
Revenue CAGR CAGR of 11.41% from 2023–2030  
Revenue Forecast by 2030 USD 2.88 Billion  
By Origin
  • Hematopoietic Cells
  • Skin Cells
  • Liver Cells
  • Renal Cells
  • Skeletal and Muscle Cells
By Type
  • Human Primary Cells
  • Animal Primary Cells
By End-User
  • Pharmaceutical & Biotechnology Companies
  • Research Institutes
Regions and Countries Covered
  • North America
  • Europe
  • Asia-Pacific
  • Middle East & Africa
  • Latin America
Base Year 2022  
Historical Year  2018 to 2021  
Forecast Year  2023 to 2030  

Inquire Before Buying This Report @

Competitive Landscape

Several companies in the global primary cells market are prioritizing acquisitions as their main strategy for business expansion. For instance, in April 2023, AnaBios Corporation acquired Cell Systems, expanding its distinctive collection of human tissues and cells. This acquisition empowers researchers to expedite drug discovery and deepen their comprehension of cell biology through an extensive array of biologically pertinent tools.

Prominent companies in the global primary cells industry include:

  • AnaBios Corporation
  • Cell Biologics, Inc.
  • Corning Incorporated
  • InvivoGen
  • Lonza Group Ltd.
  • Merck KGaA
  • PBS Biotech Inc
  • PromoCell GmbH
  • StemBioSys
  • Thermo Fisher Scientific, Inc.
  • ZenBio, Inc.
  • BioIVT
  • STEMCELL Technologies

Growing Importance of Hematopoietic Cells in Modern Biomedical Research to Boost Market Growth

Based on origin, the hematopoietic cells segment accounted for the largest share of the global primary cells market in 2022 and is expected to grow at a robust CAGR of 13.12% over the estimated period of 2023-2030. An increase in cases of blood cancer and a parallel rise in stem cell research initiatives are attributable to this significant growth. Hematopoietic cells have assumed a pivotal role in comprehending the intricate biochemical pathways of tumor cells and evaluating the efficacy of diverse pharmaceutical compounds, underlining their significance in contemporary biomedical research.

Ask for Customization:

Demand for Human Primary Cells to Soar in the Development of Cancer Therapies

In terms of type, the human primary cells segment led the global primary cells market in 2022 and is likely to grow at a healthy CAGR of 11.86% over the forecast timeline of 2023-2030. The substantial rise in demand for human primary cells is mainly attributable to their vital role in the development of cutting-edge cancer therapies. Additionally, increased financial backing for R&D initiatives in the field of cell therapy further bolsters the prominence of this segment.

Development of Promising Cancer Therapies to Drive Primary Cells Market Expansion

Over the years, there has been continuous research and development into potential cancer medicines and cures. This initiative encompasses the exploration and development of treatments like checkpoint inhibitors, cancer vaccines, and adoptive cell therapies. Although they have been refined to be more targeted and less harmful to healthy cells, chemotherapy and radiation therapy are still prominently employed to treat cancer. Natural remedies and medicinal plants are increasingly being used to cure cancer. In preclinical studies, a few plant chemicals have demonstrated promising anticancer action, and scientists are now investigating how they might be used to treat the illness.

Additionally, to raise the efficacy of existing treatments, lessen side effects, and increase the survival rates of cancer patients, researchers and businesses are consistently investigating new strategies and enhancing existing ones. This continued effort contributes significantly to the burgeoning growth of the market.

Purchase this Premium Research Report:

North America to Lead Market Owing to Growing Adoption of Cutting-edge Technologies

North America is estimated to lead the global primary cells market in the upcoming years, accruing a valuation of USD 1.16 billion by 2030. The regional market is experiencing sizable growth driven by prevalent efforts for constructing 3D models and adopting cutting-edge technologies such as gene editing and organ-on-a-chip technology. These advancements are enhancing the precision and efficiency of primary cell research.

Additionally, there is a rising interest in employing primary cells to create cell-based therapeutics for spinal cord injuries and heart disease, as well as devising specialized treatments for cancer and other disorders. Additionally, current trends in the use of primary cells in the region point to the continuation of the development and application of cutting-edge methods in primary cell research as well as an increased emphasis on the advancement of individualized and targeted disease therapies.

Browse the Complete Report Here:

Major Points from TOC:

1 Introduction of the Global Primary Cells Market 
2 Executive Summary
3 Research Methodology 
4 Global Primary Cells Market Outlook
5 Impact of Russia-Ukraine War
6 Global Primary Cells Market, By Origin
7 Global Primary Cells Market, By Type
8 Global Primary Cells Market, By End-User
9 Global Primary Cells Market, By Geography
10 North America 
11 Europe
12 Asia Pacific
13 Middle East & Africa 
14 Latin America 
15 Global Primary Cells Market Competitive Landscape
16 Company Profiles

Browse Complete TOC:

About Us:

Kings Research stands as a renowned global market research firm. With a collaborative approach, we work closely with industry leaders, conducting thorough assessments of trends and developments. Our primary objective is to provide decision-makers with tailored research reports that align with their unique business objectives. Through our comprehensive research studies, we strive to empower leaders to make informed decisions.

Our team comprises individuals with diverse backgrounds and a wealth of knowledge in various industries. At Kings Research, we offer a comprehensive range of services aimed at assisting you in formulating efficient strategies to achieve your desired outcomes. Our objective is to significantly enhance your long-term progress through these tailored solutions.

Contact Us

Kings Research
Phone: (+1) 888 328 2189
E-mail: [email protected]
Follow Us: LinkedIn | Facebook | Twitter

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. takes no editorial responsibility for the same.